Publications by authors named "Chao-Feng Mu"

Claim this Profile
T
The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone.
Cong Liu, Anzhi Hu, Huijuan Chen, Jing Liang, Mancang Gu, Chao-Feng Mu

Acta Pharm Sin B· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel-Loaded Chitosan-Cholesterol Conjugate-Based Self-Assembled Nanoparticles for Overcoming Multidrug Resistance in Cancer Cells.
Chao-Feng Mu, Fude Cui, Yong-Mei Yin, Hyun-Jong Cho, Dae-Duk Kim

Pharmaceutics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual oligopeptides modification mediates arsenic trioxide containing nanoparticles to eliminate primitive chronic myeloid leukemia cells inside bone marrow niches.
Luhui Fan, Cong Liu, Anzhi Hu, Jing Liang, Fanzhu Li, Chao-Feng Mu

Int J Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
Chao-Yuan Tang, Li-Xin Zhu, Jian-Dong Yu, Zhi Chen, Man-Cang Gu, Chao-Feng Mu

Eur J Pharm Sci· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted drug delivery for tumor therapy inside the bone marrow.
Chao-Feng Mu, Jianliang Shen, Jing Liang, Hang-Sheng Zheng, Yang Xiong

Biomaterials· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride.
Juan Wang, Yan Wei, Ya-Rong Fei, Li Fang, Hang-Sheng Zheng, Chao-Feng Mu

Int J Pharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Codelivery of Ponatinib and SAR302503 by Active Bone-Targeted Polymeric Micelles for the Treatment of Therapy-Resistant Chronic Myeloid Leukemia.
Chao-Feng Mu, Yang Xiong, Xue Bai, Yun-Jie Sheng, Jiajun Cui

Mol Pharm· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel.
Chao-Feng Mu, Prabagar Balakrishnan, Fu-De Cui, Yong-Mei Yin, Yong-Bok Lee

Biomaterials· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Yong-Mei Yin, Fu-De Cui, Chao-Feng Mu, Min-Koo Choi, Jung Sun Kim

J Control Release· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis